Neoplasms Metastasis Completed Phase 2 Trials for Bosutinib (DB06616)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00319254Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast CancerTreatment